Nanologica AB (publ) (STO:NICA)
0.4100
+0.0050 (1.23%)
Feb 11, 2026, 9:05 AM CET
Nanologica AB Revenue
Nanologica AB had revenue of 2.84M SEK in the quarter ending September 30, 2025, with 365.30% growth. This brings the company's revenue in the last twelve months to 22.65M, up 158.40% year-over-year. In the year 2024, Nanologica AB had annual revenue of 14.54M with 211.17% growth.
Revenue (ttm)
22.65M
Revenue Growth
+158.40%
P/S Ratio
1.58
Revenue / Employee
1.19M
Employees
19
Market Cap
35.79M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 14.54M | 9.87M | 211.17% |
| Dec 31, 2023 | 4.67M | -1.16M | -19.92% |
| Dec 31, 2022 | 5.83M | -8.91M | -60.43% |
| Dec 31, 2021 | 14.75M | -3.59M | -19.58% |
| Dec 31, 2020 | 18.34M | 6.12M | 50.04% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Alzinova AB | 26.12M |
| ExpreS2ion Biotech Holding AB | 10.85M |
| AcouSort AB | 10.80M |
| NanoEcho AB | 3.43M |
| OncoZenge AB | 2.78M |
| Aptahem AB | 2.47M |
| 2cureX AB | 1.98M |
| Pila Pharma AB | 957.89K |